Elevated Serum CA-125 in a Patient with Follicular Lymphoma and a History of Ovarian Cancer

A patient with a previous history of epithelial ovarian cancer presented to her physician with diffuse adenopathy. On subsequent evaluation, she was found to have a follicular lymphoma. Work-up revealed an elevated serum CA-125 antigen level, raising the question of whether the laboratory abnormalit...

Descripción completa

Detalles Bibliográficos
Autores principales: Anand, Rachna, Markman, Maurie
Formato: Texto
Lenguaje:English
Publicado: S. Karger AG 2011
Materias:
Published: March 2011
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3081648/
https://www.ncbi.nlm.nih.gov/pubmed/21526135
http://dx.doi.org/10.1159/000327322
_version_ 1782202230208724992
author Anand, Rachna
Markman, Maurie
author_facet Anand, Rachna
Markman, Maurie
author_sort Anand, Rachna
collection PubMed
description A patient with a previous history of epithelial ovarian cancer presented to her physician with diffuse adenopathy. On subsequent evaluation, she was found to have a follicular lymphoma. Work-up revealed an elevated serum CA-125 antigen level, raising the question of whether the laboratory abnormality represented evidence of recurrence of the original epithelial cancer. The subsequent major decline in this tumor marker following treatment directed to the lymphoma provided strong support for the conclusion that the elevated CA-125 was secondary to this malignant process and not ovarian cancer.
format Text
id pubmed-3081648
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-30816482011-04-27 Elevated Serum CA-125 in a Patient with Follicular Lymphoma and a History of Ovarian Cancer Anand, Rachna Markman, Maurie Case Rep Oncol Published: March 2011 A patient with a previous history of epithelial ovarian cancer presented to her physician with diffuse adenopathy. On subsequent evaluation, she was found to have a follicular lymphoma. Work-up revealed an elevated serum CA-125 antigen level, raising the question of whether the laboratory abnormality represented evidence of recurrence of the original epithelial cancer. The subsequent major decline in this tumor marker following treatment directed to the lymphoma provided strong support for the conclusion that the elevated CA-125 was secondary to this malignant process and not ovarian cancer. S. Karger AG 2011-03-29 /pmc/articles/PMC3081648/ /pubmed/21526135 http://dx.doi.org/10.1159/000327322 Text en Copyright © 2011 S. Karger AG, Basel http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No-Derivative-Works License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions.
spellingShingle Published: March 2011
Anand, Rachna
Markman, Maurie
Elevated Serum CA-125 in a Patient with Follicular Lymphoma and a History of Ovarian Cancer
title Elevated Serum CA-125 in a Patient with Follicular Lymphoma and a History of Ovarian Cancer
title_full Elevated Serum CA-125 in a Patient with Follicular Lymphoma and a History of Ovarian Cancer
title_fullStr Elevated Serum CA-125 in a Patient with Follicular Lymphoma and a History of Ovarian Cancer
title_full_unstemmed Elevated Serum CA-125 in a Patient with Follicular Lymphoma and a History of Ovarian Cancer
title_short Elevated Serum CA-125 in a Patient with Follicular Lymphoma and a History of Ovarian Cancer
title_sort elevated serum ca-125 in a patient with follicular lymphoma and a history of ovarian cancer
topic Published: March 2011
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3081648/
https://www.ncbi.nlm.nih.gov/pubmed/21526135
http://dx.doi.org/10.1159/000327322
work_keys_str_mv AT anandrachna elevatedserumca125inapatientwithfollicularlymphomaandahistoryofovariancancer
AT markmanmaurie elevatedserumca125inapatientwithfollicularlymphomaandahistoryofovariancancer

Ejemplares similares